LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration

Author(s):  Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A

Issue:  Jul/Aug 2008 - Hormone Replacement Therapy
View All Articles in Issue

Abstract:  The objective of this study was to evaluate the physical and chemical stability of undiluted palonosetron hydrochloride 50 mcg/mL when mixed with undiluted glycopyrrolate 0.2 mg/mL and neostigmine methylsulfate 0.5 mg/mL during simulated Y-site administration. Duplicate test samples were prepared by admixing 7.5 mL of palonosetron hydrochloride with 7.5 mL of glycopyrrolate and neostigmine methylsulfate injections. Physical stability was assessed by using a multi-step evaluation procedure that included both turbidimetric and particulate measurements and visual inspection. Chemical stability was assessed by using stability-indicating high-performance liquid chromatography analytical techniques based on the determination of drug concentrations. Evaluations were performed initially upon mixing and 1 and 4 hours after mixing. The samples were clear and colorless when viewed in normal fluorescent room light and when viewed with a Tyndall beam. Measured turbidity remained unchanged and particulate content was low a

Related Keywords: Craig Trusley, PharmD, MS, Thomas C. Kupiec, PhD, Lawrence A. Trissel, BS, RPh, FASHP, palonosetron hydrochloride, 5-HT3 blocker, glycopyrrolate, neostigmine, parenteral administration, infusion, stability, drug admixtures, compatibility, nausea, vomiting, antiemetic agent, Michel Ben, BS

Related Categories: CANCER AND AIDS, GASTROENTEROLOGY, PARENTERALS, STABILITIES, COMPATIBILITIES, NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A Jul/Aug 2008 368-371 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A Mar/Apr 2008 156-160 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A Mar/Apr 2008 170-173 Buy
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A Nov/Dec 2007 520-524 Buy
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel Jan/Feb 2009 78-80 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A Sep/Oct 2008 460-462 Buy
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Trusley Craig, Kupiec Thomas C, Trissel Lawrence A May/Jun 2006 230-233 Buy
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A May/Jun 2008 276-278 Buy
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A May/Jun 2005 238-241 Buy
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A May/Jun 2005 235-237 Buy